A Study of Combination Spartalizumab and Canakinumab in Patients With Localized Clear Cell Renal Cell Carcinoma
Clinical trial NCT04028245 · COMPLETED
Trial details
- NCT number
- NCT04028245
- Sponsor
- Columbia University
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-15
- Primary completion
- 2025-03-14
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.